249 related articles for article (PubMed ID: 31090950)
1. Black Swans of CRISPR: Stochasticity and Complexity of Genetic Regulation.
Cheong KH; Koh JM; Jones MC
Bioessays; 2019 Jul; 41(7):e1900032. PubMed ID: 31090950
[TBL] [Abstract][Full Text] [Related]
2. Gene editing and gene regulation with CRISPR.
Harrison P; Hart S
Exp Physiol; 2018 Apr; 103(4):437-438. PubMed ID: 29603460
[No Abstract] [Full Text] [Related]
3. Meeting Report: German Genetics Society-Genome Editing with CRISPR.
Maier LK; Marchfelder A; Randau L
Bioessays; 2020 Feb; 42(2):e1900223. PubMed ID: 31853989
[No Abstract] [Full Text] [Related]
4. CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.
Duroux-Richard I; Giovannangeli C; Apparailly F
Joint Bone Spine; 2017 Jan; 84(1):1-4. PubMed ID: 27825565
[No Abstract] [Full Text] [Related]
5. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
Xu R; Wei P; Yang J
Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
Hashemi A
Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
[TBL] [Abstract][Full Text] [Related]
7. The Biology and Application Areas of CRISPR Technologies.
Adli M
J Mol Biol; 2019 Jan; 431(1):1-2. PubMed ID: 30447221
[No Abstract] [Full Text] [Related]
8. CRISPR technologies for bacterial systems: Current achievements and future directions.
Choi KR; Lee SY
Biotechnol Adv; 2016 Nov; 34(7):1180-1209. PubMed ID: 27566508
[TBL] [Abstract][Full Text] [Related]
9. Targeted Base Editing Systems Are Available for Plants.
Marzec M; Hensel G
Trends Plant Sci; 2018 Nov; 23(11):955-957. PubMed ID: 30224156
[TBL] [Abstract][Full Text] [Related]
10. Cutting Edge Genetics: CRISPR/Cas9 Editing of Plant Genomes.
Soyars CL; Peterson BA; Burr CA; Nimchuk ZL
Plant Cell Physiol; 2018 Aug; 59(8):1608-1620. PubMed ID: 29912402
[TBL] [Abstract][Full Text] [Related]
11. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
Cho S; Shin J; Cho BK
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas9 System: Opportunities and Concerns.
Vasiliou SK; Diamandis EP; Church GM; Greely HT; Baylis F; Thompson C; Schmitt-Ulms G
Clin Chem; 2016 Oct; 62(10):1304-11. PubMed ID: 27551006
[No Abstract] [Full Text] [Related]
13. [CRISPR-Cas system as molecular scissors for gene therapy].
Heinz GA; Mashreghi MF
Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
[TBL] [Abstract][Full Text] [Related]
14. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
15. Advancing biotechnology with CRISPR/Cas9: recent applications and patent landscape.
Ferreira R; David F; Nielsen J
J Ind Microbiol Biotechnol; 2018 Jul; 45(7):467-480. PubMed ID: 29362972
[TBL] [Abstract][Full Text] [Related]
16. Cas9 immunity creates challenges for CRISPR gene editing therapies.
Crudele JM; Chamberlain JS
Nat Commun; 2018 Aug; 9(1):3497. PubMed ID: 30158648
[TBL] [Abstract][Full Text] [Related]
17. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
[TBL] [Abstract][Full Text] [Related]
19. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
Ahmad G; Amiji M
Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
[TBL] [Abstract][Full Text] [Related]
20. A CRISPR-dCas Toolbox for Genetic Engineering and Synthetic Biology.
Xu X; Qi LS
J Mol Biol; 2019 Jan; 431(1):34-47. PubMed ID: 29958882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]